Fibromyalgis/Pain Syndromes

Muscle fatigue in fibromyalgia is in the brain, not in the muscles: a case–control study of perceived versus objective muscle fatigue
Elisabeth Bandak, Kirstine Amris, Henning Bliddal, Bente Danneskiold-Samsøe, Marius Henriksen

Annals of the Rheumatic Diseases Jun 2013, 72 (6) 963-966; DOI: 10.1136/annrheumdis-2012-202340
Irritable bowel syndrome symptoms in axial spondyloarthritis more common than among healthy controls: is it an overlooked comorbidity?
Johan Karlsson Wallman, Elisabeth Mogard, Jan Marsal, Kristofer Andréasson, Anna Jöud, Mats Geijer, Lars Erik Kristensen, Elisabet Lindqvist, Tor Olofsson

Annals of the Rheumatic Diseases Jan 2020, 79 (1) 159-161; DOI: 10.1136/annrheumdis-2019-216134
Efficacy and safety of fasinumab in patients with chronic low back pain: a phase II/III randomised clinical trial
Paula Dakin, Alan J Kivitz, Joseph S Gimbel, Nebojsa Skrepnik, Stephen J DiMartino, Chetachi A Emeremni, Haitao Gao, Neil Stahl, David M Weinreich, George D Yancopoulos, Gregory P Geba

Annals of the Rheumatic Diseases Apr 2021, 80 (4) 509-517; DOI: 10.1136/annrheumdis-2020-217259
Response to: ‘Correspondence on: irritable bowel syndrome symptoms in axial spondyloarthritis more common than among healthy controls: is it an overlooked comorbidity?’ by Proft et al.
Johan Karlsson Wallman, Elisabeth Mogard, Jan Marsal, Kristofer Andréasson, Anna Jöud, Mats Geijer, Lars Erik Kristensen, Elisabet Lindqvist, Tor Olofsson

Annals of the Rheumatic Diseases Jan 2022, 81 (1) e10; DOI: 10.1136/annrheumdis-2019-216752
Response to: ‘ “Evaluation of the impact of concomitant fibromyalgia on TNF alpha blockers’ effectiveness in axial spondyloarthritis: results of a prospective, multicentre study” by Moltó et al: still a long way to go in the assessment of patients with spondyloarthritis and concomitant fibromyalgia?’ by Altobelli et al
Anna Moltó, Maxime Dougados

Annals of the Rheumatic Diseases May 2019, 78 (5) e40; DOI: 10.1136/annrheumdis-2018-213419
‘Evaluation of the impact of concomitant fibromyalgia on TNF alpha blockers’ effectiveness in axial spondyloarthritis: results of a prospective, multicentre study’ by Moltó et al: still a long way to go in the assessment of patients with spondyloarthritis and concomitant fibromyalgia?
Alessio Altobelli, Rossana Scrivo, Guido Valesini

Annals of the Rheumatic Diseases May 2019, 78 (5) e39; DOI: 10.1136/annrheumdis-2018-213319
Persons with chronic widespread pain experience excess mortality: longitudinal results from UK Biobank and meta-analysis
Gary J Macfarlane, Maxwell S Barnish, Gareth T Jones

Annals of the Rheumatic Diseases Nov 2017, 76 (11) 1815-1822; DOI: 10.1136/annrheumdis-2017-211476
Chronic widespread pain and increased mortality: biopsychosocial interconnections
Jose A P Da Silva, Rinie Geenen, Johannes W G Jacobs

Annals of the Rheumatic Diseases Jun 2018, 77 (6) 790-792; DOI: 10.1136/annrheumdis-2017-211893
Autoantibodies to citrullinated proteins may induce joint pain independent of inflammation
Gustaf Wigerblad, Duygu B Bas, Cátia Fernades-Cerqueira, Akilan Krishnamurthy, Kutty Selva Nandakumar, Katarzyna Rogoz, Jungo Kato, Katalin Sandor, Jie Su, Juan Miguel Jimenez–Andrade, Anja Finn, Alex Bersellini Farinotti, Khaled Amara, Karin Lundberg, Rikard Holmdahl, Per-Johan Jakobsson, Vivianne Malmström, Anca I Catrina, Lars Klareskog, Camilla I Svensson

Annals of the Rheumatic Diseases Apr 2016, 75 (4) 730-738; DOI: 10.1136/annrheumdis-2015-208094
EULAR revised recommendations for the management of fibromyalgia
G J Macfarlane, C Kronisch, L E Dean, F Atzeni, W Häuser, E Fluß, E Choy, E Kosek, K Amris, J Branco, F Dincer, P Leino-Arjas, K Longley, G M McCarthy, S Makri, S Perrot, P Sarzi-Puttini, A Taylor, G T Jones

Annals of the Rheumatic Diseases Feb 2017, 76 (2) 318-328; DOI: 10.1136/annrheumdis-2016-209724

Main menu

Fibromyalgis/Pain Syndromes

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Fibromyalgis/Pain Syndromes

Pages